Cardium Announces First International Marketing and Distribution Agreement for Commercialization of Excellagen in South Korea - Sprinklr (NYSE:CXM)

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.

Cardium Therapeutics (NYSE: CXM)today announced that it has entered into its first international agreement forthe commercialization of Excellagen in the South Korean market. Cardiumentered into a marketing and distribution agreement with BL&H Co. Ltd., anestablished pharmaceutical company based in Korea, for the commercializationof Excellagen Formulated Fibrillar Collagen Gel in the South Korean marketunder a transfer price arrangement as further described below.

27% profits every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!